Caplin Point Laboratories Ltd vs Zenith Drugs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 08, 2026

Key Highlights

The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 1857 as of 08 May 15:30 . The P/E Ratio of Caplin Point Laboratories Ltd changed from 12.6 on March 2021 to 28.4 on March 2025 . This represents a CAGR of 17.65% over 5 yearsThe P/E Ratio of Zenith Drugs Ltd changed from 11.2 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 years The Market Cap of Caplin Point Laboratories Ltd changed from ₹ 3057 crore on March 2021 to ₹ 15222 crore on March 2025 . This represents a CAGR of 37.86% over 5 yearsThe Market Cap of Zenith Drugs Ltd changed from ₹ 107.52 crore on March 2024 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 2 years The revenue of Caplin Point Laboratories Ltd for the Dec '25 is ₹ 576.45 crore as compare to the Sep '25 revenue of ₹ 564.43 crore. This represent the growth of 2.13% The revenue of Zenith Drugs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Caplin Point Laboratories Ltd for the Dec '25 is ₹ 223.35 crore as compare to the Sep '25 ebitda of ₹ 219.56 crore. This represent the growth of 1.73% The ebitda of Zenith Drugs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Caplin Point Laboratories Ltd changed from ₹ 124.92 crore to ₹ 165.86 crore over 7 quarters. This represents a CAGR of 17.58% The net profit of Zenith Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Caplin Point Laboratories Ltd changed from 14.53 % on March 2021 to 13.43 % on March 2025 . This represents a CAGR of -1.56% over 5 yearsThe Dividend Payout of Zenith Drugs Ltd changed from 8.99 % on March 2024 to 0 % on March 2025 . This represents a CAGR of -100.00% over 2 years .

About Caplin Point Laboratories Ltd

Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16, 1990.
The Company is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.

About Zenith Drugs Ltd

Zenith Drugs Limited was originally incorporated on November 15, 2000 as a Private Limited Company as 'Zenith Drugs Private Limited' issued by the Registrar of Companies, in the State of Madhya Pradesh, Gwalior.
Subsequently, Company was converted into Public Limited and consequently, the name of the Company was changed to Zenith Drugs Limited' pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior. Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore.
Zenith's core business centers on production of high-quality, cost-effective pharmaceutical formulations such as: ORS Powder; Liquid Orals; Oinments; Liquid Externals and Capsules.
With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients.

FAQs for the comparison of Caplin Point Laboratories Ltd and Zenith Drugs Ltd

Which company has a larger market capitalization, Caplin Point Laboratories Ltd or Zenith Drugs Ltd?

Market cap of Caplin Point Laboratories Ltd is 14,118 Cr while Market cap of Zenith Drugs Ltd is 77 Cr

What are the key factors driving the stock performance of Caplin Point Laboratories Ltd and Zenith Drugs Ltd?

The stock performance of Caplin Point Laboratories Ltd and Zenith Drugs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Caplin Point Laboratories Ltd and Zenith Drugs Ltd?

As of May 8, 2026, the Caplin Point Laboratories Ltd stock price is INR ₹1857.35. On the other hand, Zenith Drugs Ltd stock price is INR ₹45.35.

How do dividend payouts of Caplin Point Laboratories Ltd and Zenith Drugs Ltd compare?

To compare the dividend payouts of Caplin Point Laboratories Ltd and Zenith Drugs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.